Metabolic labelling of cancer cells with glycodendrimers stimulate immune-mediated cytotoxicity

David Goyard1, Peremobowei Iyanu Diriwari1, Nathalie Berthet1

  • 1Univ. Grenoble Alpes, CNRS DCM UMR 5250 F-38000 Grenoble France nathalie.berthet@univ-grenoble-alpes.fr.

RSC Medicinal Chemistry
|February 25, 2022
PubMed

Insights

This study introduces a novel cancer immunotherapy approach using bio-orthogonal click chemistry to recruit natural antibodies to cancer cells, activating immune responses without complex molecular engineering.

Area of Science:

  • Immunotherapy
  • Bioconjugation Chemistry
  • Cancer Biology

Background:

  • Recruiting natural antibodies to cancer cells is a promising immunotherapy strategy.
  • Existing antibody recruiting molecules (ARMs) face challenges in optimizing complex formation for effective immune response.

Purpose of the Study:

  • To develop a direct method for recruiting natural antibodies to cancer cells using bio-orthogonal click chemistry.
  • To enable antibody binding module (ABM) conjugation to the cell glycocalyx via cell metabolism of azido-sugar.

Main Methods:

  • Utilized cell metabolism of azido-sugar for glycan modification.
  • Employed bio-orthogonal click chemistry for precise ABM conjugation to the cell surface.
  • Tested the strategy on isolated cells and solid tumor models.

Main Results:

  • Successfully recruited natural antibodies to the surface of cancer cells.
  • Demonstrated activation of a cytotoxic immune response using only human serum.
  • Validated the approach in both isolated cell and solid tumor models.

Conclusions:

  • This direct conjugation strategy effectively recruits natural antibodies to cancer cells.
  • The method activates immune-mediated cytotoxicity, offering a simplified immunotherapeutic approach.
  • The technique shows potential for fighting cancer by leveraging the body's natural immune defenses.